Celon Pharma SA Capital Reinvestment Ratio
Celon Pharma SA capital reinvestment ratio. Celon Pharma SA (CLN) has a Capital Reinvestment Ratio of 0.72x as of December 2025, meaning it reinvests 1% of its operating cash flow (zł36.63 Million) in capital expenditures (zł26.48 Million). See Celon Pharma SA free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Celon Pharma SA (2012–2025)
Capital reinvestment ratio of Celon Pharma SA from 2012 to 2025. This chart tracks Celon Pharma SA's Capital Reinvestment Ratio across 10 annual periods. See Celon Pharma SA financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Celon Pharma SA Capital Reinvestment Ratio by Year (2012–2025)
Celon Pharma SA capital reinvestment ratio by year from 2012 to 2025. For the full cash flow conversion analysis, see CLN cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.28x | zł23.86 Million | zł54.44 Million | ▲ +142.4% |
| 2021 | 0.94x | zł43.95 Million | zł41.35 Million | ▼ -32.7% |
| 2020 | 1.40x | zł70.90 Million | zł99.16 Million | ▼ -41.5% |
| 2018 | 2.39x | zł28.24 Million | zł67.46 Million | ▲ +92.9% |
| 2017 | 1.24x | zł25.30 Million | zł31.34 Million | ▲ +20.1% |
| 2016 | 1.03x | zł20.65 Million | zł21.29 Million | ▲ +20.4% |
| 2015 | 0.86x | zł52.37 Million | zł44.86 Million | ▼ -7.5% |
| 2014 | 0.93x | zł24.36 Million | zł22.55 Million | ▲ +38.6% |
| 2013 | 0.67x | zł8.45 Million | zł5.64 Million | ▲ +97.8% |
| 2012 | 0.34x | zł12.87 Million | zł4.34 Million | — |